Making routine health testing convenient, affordable and actionable for today’s connected consumers.

Our compact, automated system rapidly produces lab-accurate results for a full suite of tests from a small sample of blood, giving individuals unprecedented access to information that shapes their health.

Technology

Truvian is a healthcare company at the intersection of diagnostics and consumer tech.

Our automated benchtop system is being developed to produce lab-accurate results for a full suite of health tests using a single, small sample of blood. Powered by patented technologies and intelligent integration, Truvian delivers a convenient
and affordable alternative to off-site labs, providing immediate insights
to inform healthcare decisions.

LAB-ACCURATE AND AFFORDABLE

No single on-site diagnostic platform, until now, has covered such a wide range of analytes while providing accuracy that rivals off-site labs. By combining multiple tests into one system, clinics and individuals see significant savings.

MULTIPLE ASSAYS ON ONE PLATFORM

Patented diagnostic technology enables comprehensive blood testing encompassing chemistries, imunoassays, and hematology assays using a small sample of blood. Results are produced on site within minutes and delivered to patients.

COMPACT SYSTEM WITH SHELF-STABLE REAGENTS

Truvian’s benchtop diagnostic system is designed to fit seamlessly into a clinic’s space and workflow. It’s compact and easy to run, using novel reagent technology that does not require refrigeration.

How is this rollover going to look Learn more<br>How is this rollover going to look Learn more<br>How is this rollover going to look Learn more<br>How is this rollover going to look Learn more<br>How is this rollover going to look Learn more<br>How is this rollover going to look Learn more<br>How is this rollover going to look Learn more<br>How is this rollover going to look Learn more<br>How is this rollover going to look Learn more<br>How is this rollover going to look Learn more<br>How is this rollover going to look <a href="http://www.google.com">Learn more</a>

Automated system enables the combination of chemistries, immunoassays, and hematology assays on one benchtop device.
Compact and fully automated bench-top instrument is engineered for clinic convenience, with remote monitoring and serviceability.
Dry reagent technology means consumables can be stored at room temperature, eliminating cold chain and refrigeration.
Fast, accurate results are delivered electronically to individuals through a secure, easy-to-use digital platform.

News

Truvian Sciences Accelerates Plans With $27.1 Million Series B Financing to Develop an Automated Benchtop Blood Testing System for Rapid Assessment of a Full Suite of Health Tests

Meet the Truvian Team

Truvian Sciences was founded in 2015 by individuals with deep domain experience in healthcare, diagnostics, and consumer technology. Today, the team has expanded to include top scientists, engineers, and healthcare business leaders — each bringing specialized expertise to drive Truvian’s mission. Together, we are advancing a benchtop diagnostic system and full suite of assays that health clinics can use to produce actionable blood-test results within minutes. Our software platform allows practitioners to deliver data to patients instantaneously on a secure and easy-to-use mobile platform.

Executive Leadership

Jeff Hawkins
President and Chief Executive Officer

Click for bio...

For almost 20 years, Mr. Hawkins has held executive and management roles at the world’s leading healthcare companies. Specializing in the advancement of life-changing technologies, Mr. Hawkins joined Truvian Sciences as President and Chief Executive Officer in January 2018. Prior to Truvian, Mr. Hawkins was Vice President and General Manager of the Reproductive and Genetic Health Business at Illumina, Inc. Before Illumina, he served as Senior Vice President of Global Marketing and Program Management for GenMark Diagnostics. Previously, Mr. Hawkins held roles of increasing responsibility in business development for Hologic, Third Wave Technologies and Abbott Laboratories. Mr. Hawkins holds a B.A. in Chemistry with honors from Concordia University and an M.B.A. from Keller Graduate School of Management.

Katherine Atkinson
Chief Commercial Officer

Click for bio...

Ms. Atkinson has more than 20 years of experience in the healthcare and life sciences industries, where she continuously creates customer-focused teams that achieve and exceed global commercial and sales goals. Prior to joining Truvian, Ms. Atkinson served as Epic Sciences’ Chief Commercial Officer, where she identified new strategic business opportunities and deepened existing strategic partnerships. Prior to Epic, Ms. Atkinson was Vice President of Business Development and Strategic partnerships at Edico Genome. Previously, she held roles of increasing responsibility at Illumina, including as Commercial Director of Global Channel Partners and Director, Global Channel Partners, LATAM & Inside Sales, Demand Generation and Product Care Teams. Ms. Atkinson’s previous experience also includes leadership roles at Fisher Scientific, Thermo Fisher and Beckman Coulter. She holds a B.A in Broadcast Journalism and Public Speaking from the University of Houston.

Dena Marrinucci Ph.D.
Co-Founder and Senior Vice President of Corporate Development and Business Operations

Click for bio...

Dr. Marrinucci is a life science entrepreneur with a passion for introducing diagnostic technologies with potential to transform human health. She co-founded Truvian in late 2015 and leads research, operations, program management and strategic partnerships for the company. Prior to founding Truvian, Dr. Marrinucci founded Epic Sciences in 2008 and was the company’s Chief Scientific Officer. During her tenure at Epic, Dr. Marrinucci developed a novel circulating tumor cell technology and helped grow the company, overseeing its diagnostic collaborations with pharmaceutical companies and developing its clinical laboratory and assay development operations.

Dr. Marrinucci has been named to MIT Technology Review’s 35 Innovators Under 35, Foreign Policy’s Top 100 Leading Global Thinkers, and PharmaVoice 100’s Top Entrepreneurs. She was also named a 2016 Life Science Catalyst Award winner, has authored dozens of peer reviewed publications and is an inventor on 12 patents. Dr. Marrinucci also serves as an Advisor for Lynx Biosciences, a cancer diagnostic company. She holds a B.S. in Chemistry from the University of Vermont and a Ph.D. in Chemical Biology from The Scripps Research Institute.

Tho Tran
Vice President of Quality and
Regulatory Affairs

Click for bio...

Mr. Tran brings Truvian extensive experience in the medical device and diagnostics space, where he specializes in quality management and regulatory compliance. Throughout his career, he has orchestrated a variety of successful regulatory submissions and audits with the FDA, Health Canada, European Commission and other quality governing bodies worldwide. At Truvian, he is instrumental in the company’s plans toward securing FDA 510(k) clearance. Mr. Tran’s career in quality assurance includes his role as Director of Quality at GenMark Diagnostics, a leading provider of automated, multiplex molecular diagnostic testing systems. He has also held engineering roles with Life Technologies, Flextronics Medical, and Abbott Laboratories, where he was recognized with a management award for his leadership in implementing a new quality system and ProChain Project Management approach. Mr. Tran holds a B.S. from the School of Health Sciences at Excelsior College.

Board of Directors

Kim Kamdar, Ph.D.

Click for bio...

Dr. Kamdar is a Partner with Domain Associates, a healthcare venture capital leader. With a background in small molecule drug discovery, she has been involved in cutting-edge therapeutic start-ups and has been a major part of identifying companies with promising molecular and companion diagnostics to support personalized medicine. Dr. Kamdar is currently Chair of the Board of Directors of Obalon Therapeutics and serves on the boards of Epic Sciences, Evofem Biosciences, Omniome and Sera Prognostics. She is also a board member of San Diego's CONNECT Foundation and an advisory board member of Eric Topol’s NIH-supported Clinical and Translational Science Award for Scripps Medicine.

Dr. Kamdar is the author of 10 papers as well as the inventor on seven patents. She received her B.A. from Northwestern University and her Ph.D. in Biochemistry and Genetics from Emory University.

Jeff Hawkins

Click for bio...

Ashok Krishnamurthi

Click for bio...

Mr. Krishnamurthi is Managing Partner at Greatpoint Ventures, a California-based venture capital firm. A serial entrepreneur and investor, Mr. Krishnamurthi is focused on enterprise IT, and the intersection of computer science and life sciences. He founded two medical related companies – CAPP Medical, a liquid biopsy company for cancer diagnosis (sold to Roche Diagnostics), and CiberMed which focuses on biomarker discovery. He is currently a Board member of Activ Surgical, EVEN Financial, Insight-rx, Namogoo, Recogni and Scoredata.

Mr. Krishnamurthi has a B.S. in Electrical Engineering from Manipal Institute of Technology and a M.S. in Computer Engineering from Syracuse University.

Paul Meister

Click for bio...

Mr. Meister brings over three decades of experience to Truvian’s board, serving in senior executive and board roles for high-growth and publicly traded companies. Most recently, Mr. Meister served as President of MacAndrews & Forbes Incorporated, a private company that owns or controls a diverse set of companies, including Revlon, Scientific Games, Harlan Clarke Corp., and SIGA Technologies. Prior to that role, he was Chairman and CEO of inVentiv Health (now Syneos Health) and Chairman of the Board at Thermo Fisher Scientific. Mr. Meister co-founded Liberty Lane Partners, LLC, a private investment company and Perspecta Trust, a trust company that provides trust and investment services. He is currently Director of the boards at Arbor Biotechnologies, Inc., Core & Main LP, Magnolia Medical Technologies, Inc., PharmaLegacy Laboratories (Shanghai) Co., Ltd., Quanterix Corporation, Revlon, Inc., Scientific Games Corporation and Wheelabrator Technologies Holdings Inc., as well as Vice Chairman at The General Chemical Group.

Mr. Meister holds a B.A. from the University of Michigan and a M.B.A from Northwestern University's Kellogg School of Management.

We do meaningful work.

We think big.

We set standards higher.

We don’t give up.

We trust and respect each other.

We laugh every day.

Truvian’s core values are the foundation of the company and guide us in everything we do. They reflect who we are as people and how we work together and with the outside world. We are seeking exceptional individuals across assay development, engineering, quality, technical operations and manufacturing who exemplify these values and who are passionate about making an impact in healthcare. If that sounds like you, and you want to help us realize our vision, please join our growing team! careers@truvianhealth.com

Contact Us

Check out our Linkedin page for jobs.

truvianhealth.com